| Code | Description | Claims | Beneficiaries | Total Paid |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,737 |
2,891 |
$114K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,243 |
1,762 |
$108K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,630 |
1,871 |
$79K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,144 |
878 |
$46K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
3,294 |
2,451 |
$32K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
386 |
295 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
190 |
141 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
87 |
75 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
197 |
152 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
142 |
111 |
$2K |
| 87077 |
|
297 |
224 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
97 |
67 |
$962.16 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
43 |
35 |
$452.17 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
65 |
57 |
$152.84 |
| S9999 |
Sales tax |
207 |
152 |
$19.99 |